Halozyme Appoints Communications VP

James S. Mazzola has been appointed vice president, corporate communications and investor relations, Halozyme Therapeutics, Inc. He reports to president and chief executive officer Dr. Helen Torley.
 
Mr. Mazzola will be responsible for the creation and implementation of communication and branding efforts that support business objectives to key stakeholders, including investors, employees, media, corporate partners, patients, clinicians and the scientific community.
 
Mr. Mazzola has 25 years of public relations, financial communication and marketing communication experience. He previously served as senior vice president of global marketing, communication and investor relations for CareFusion. Prior to that, he was senior vice president of global communication at Cardinal Health, where he led corporate public relations, financial communication and the Cardinal Health Foundation.
 
“As we grow our business, Jim will play a key role helping to shape our brand, support our investor outreach and align our marketing communication efforts across all stakeholders,” said Dr. Torley. “His background makes him a strong complement to the very senior management team we have been building to drive results in our product programs, make a difference in the lives of patients and continue to create value for shareholders.”